Richardson, T. G., Leyden, G. M., Wang, Q., Bell, J. A., Elsworth, B., Davey Smith, G., & Holmes, M. V. (2022). Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation. PLoS biology, 20(2), e3001547. https://doi.org/10.1371/journal.pbio.3001547
Citácia podle Chicago (17th ed.)Richardson, Tom G., Genevieve M. Leyden, Qin Wang, Joshua A. Bell, Benjamin Elsworth, George Davey Smith, a Michael V. Holmes. "Characterising Metabolomic Signatures of Lipid-modifying Therapies Through Drug Target Mendelian Randomisation." PLoS Biology 20, no. 2 (2022): e3001547. https://doi.org/10.1371/journal.pbio.3001547.
Citácia podľa MLA (8th ed.)Richardson, Tom G., et al. "Characterising Metabolomic Signatures of Lipid-modifying Therapies Through Drug Target Mendelian Randomisation." PLoS Biology, vol. 20, no. 2, 2022, p. e3001547, https://doi.org/10.1371/journal.pbio.3001547.